Key components of post-diagnostic support for people with dementia and their carers: A qualitative study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 29 07 2021
accepted: 10 11 2021
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 20 1 2022
Statut: epublish

Résumé

There has been a shift in focus of international dementia policies from improving diagnostic rates to enhancing the post-diagnostic support provided to people with dementia and their carers. There is, however, little agreement over what constitutes good post-diagnostic support. This study aimed to identify the components of post-diagnostic dementia support. We adopted a qualitative design using interviews, focus groups and observation to explore the perspectives of key stakeholders on the content of post-diagnostic dementia support. Purposive sampling was used to identify sites in England and Wales recognised as delivering good practice. Participants included 17 people with dementia, 31 carers, 68 service managers or funders, and 78 frontline staff. Interviews and focus groups were audio recorded and transcribed for analysis. Forty-eight sessions of observation were completed and recorded in fieldnotes. Components were identified through an inductive, thematic approach and cross-checked against national guidelines and existing frameworks; they were subsequently critically reviewed by a range of experts and our mixed stakeholder panel. Twenty distinct components of post-diagnostic support were identified, related to five themes: timely identification and management of needs; understanding and managing dementia; emotional and psychological wellbeing; practical support; and integrating support. The first and last of these were cross-cutting themes facilitating the delivery of a unique constellation of components of post-diagnostic support to each individual living with dementia or dyad at a particular time. Our work offers an empirically based framework to inform the development and delivery of holistic, integrated and continuous dementia care from diagnosis to end of life. It highlights the relevance of many components to both people living with dementia and their carers. Since the framework was developed in England and Wales, further research is needed to explore the relevance of our components to other sectors, countries and care systems.

Sections du résumé

BACKGROUND
There has been a shift in focus of international dementia policies from improving diagnostic rates to enhancing the post-diagnostic support provided to people with dementia and their carers. There is, however, little agreement over what constitutes good post-diagnostic support. This study aimed to identify the components of post-diagnostic dementia support.
METHODS
We adopted a qualitative design using interviews, focus groups and observation to explore the perspectives of key stakeholders on the content of post-diagnostic dementia support. Purposive sampling was used to identify sites in England and Wales recognised as delivering good practice. Participants included 17 people with dementia, 31 carers, 68 service managers or funders, and 78 frontline staff. Interviews and focus groups were audio recorded and transcribed for analysis. Forty-eight sessions of observation were completed and recorded in fieldnotes. Components were identified through an inductive, thematic approach and cross-checked against national guidelines and existing frameworks; they were subsequently critically reviewed by a range of experts and our mixed stakeholder panel.
RESULTS
Twenty distinct components of post-diagnostic support were identified, related to five themes: timely identification and management of needs; understanding and managing dementia; emotional and psychological wellbeing; practical support; and integrating support. The first and last of these were cross-cutting themes facilitating the delivery of a unique constellation of components of post-diagnostic support to each individual living with dementia or dyad at a particular time.
CONCLUSIONS
Our work offers an empirically based framework to inform the development and delivery of holistic, integrated and continuous dementia care from diagnosis to end of life. It highlights the relevance of many components to both people living with dementia and their carers. Since the framework was developed in England and Wales, further research is needed to explore the relevance of our components to other sectors, countries and care systems.

Identifiants

pubmed: 34928972
doi: 10.1371/journal.pone.0260506
pii: PONE-D-21-24598
pmc: PMC8687564
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0260506

Subventions

Organisme : Department of Health
ID : NF-SI-0616-10054
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Br J Gen Pract. 2012 Feb;62(595):e91-8
pubmed: 22520775
Int J Geriatr Psychiatry. 2021 Oct;36(10):1488-1500
pubmed: 34043846
Front Psychiatry. 2020 Sep 09;11:578015
pubmed: 33033486
Age Ageing. 2016 Jan;45(1):148-54
pubmed: 26582758
Br J Gen Pract. 2020 May 28;70(695):e434-e441
pubmed: 32424049
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Can J Public Health. 2021 Jun;112(3):400-411
pubmed: 33825134
Cochrane Database Syst Rev. 2019 Apr 15;4:CD010412
pubmed: 30982950
Health Soc Care Community. 2020 Nov;28(6):1915-1927
pubmed: 32671922
Aging Ment Health. 2021 Jul;25(7):1281-1288
pubmed: 32954794
Arch Gerontol Geriatr. 2021 Nov-Dec;97:104471
pubmed: 34289415
Health Soc Care Community. 2020 Nov;28(6):1942-1960
pubmed: 32542963
Int J Geriatr Psychiatry. 2022 Jan;37(1):
pubmed: 34564897
Age Ageing. 2015 Nov;44(6):985-93
pubmed: 26504119
Alzheimers Dement (Amst). 2019 Mar 07;11:231-247
pubmed: 30906845
BMC Geriatr. 2021 May 10;21(1):301
pubmed: 33971847
Gerontol Geriatr Med. 2021 May 31;7:23337214211020164
pubmed: 34104687
BMC Geriatr. 2019 Mar 27;19(1):94
pubmed: 30917790
Clin Interv Aging. 2014 Nov 27;9:2055-63
pubmed: 25506210
Health Policy. 2021 Aug;125(8):1013-1022
pubmed: 34210512
J Alzheimers Dis. 2020;78(4):1775-1782
pubmed: 33285638
Age Ageing. 2021 May 5;50(3):657-663
pubmed: 33481988
BMJ Open. 2020 Sep 21;10(9):e040348
pubmed: 32958494
Aging Ment Health. 2021 Aug;25(8):1381-1394
pubmed: 32911966
Age Ageing. 2017 May 1;46(3):393-400
pubmed: 27916749
Age Ageing. 2021 Nov 10;50(6):2230-2237
pubmed: 34240114
Int J Geriatr Psychiatry. 2021 Jul;36(7):1120-1121
pubmed: 33961712
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285

Auteurs

Claire Bamford (C)

Faculty of Medical Sciences, Population Health Sciences Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom.

Alison Wheatley (A)

Faculty of Medical Sciences, Population Health Sciences Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom.

Greta Brunskill (G)

Faculty of Medical Sciences, Population Health Sciences Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom.

Laura Booi (L)

Faculty of Medical Sciences, Population Health Sciences Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom.

Louise Allan (L)

South Cloisters, University of Exeter, Exeter, United Kingdom.

Sube Banerjee (S)

Office of Vice Chancellor, University of Plymouth, Plymouth, United Kingdom.

Karen Harrison Dening (K)

Dementia UK, London, United Kingdom.

Jill Manthorpe (J)

NIHR Policy Research Unit in Health and Social Care Workforce, The Policy Institute at King's, King's College London, London, United Kingdom.

Louise Robinson (L)

Faculty of Medical Sciences, Population Health Sciences Institute, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH